ZOLL Medical Corp. (ZOLL) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts ZOLL Hot Sheet
Price: $93.00 --0%
Financial Fact:
General and administrative: 14.43M
Today's EPS Names:
TAYD, TMQ, OMH, More
Financial Fact:
General and administrative: 14.43M
Today's EPS Names:
TAYD, TMQ, OMH, More
Join SI Premium – FREE
ZOLL Medical Corp. (NASDAQ: ZOLL) reported Q2 EPS of $0.27, $0.07 better than the analyst estimate of $0.20. Revenue for the quarter came in at $122.5 million versus the consensus estimate of $121.05 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- RPM International (RPM) Tops Q1 EPS by 3c
- Cal-Maine Foods (CALM) Misses Q1 EPS by 79c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
